Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage

Carcinogenesis. 1999 Feb;20(2):199-203. doi: 10.1093/carcin/20.2.199.


DNA-dependent protein kinase (DNA-PK) and poly(ADP-ribose) polymerase (PARP) are activated by DNA strand breaks and participate in DNA repair. We investigated the interactive effects of inhibitors of these enzymes [wortmannin (WM), which inhibits DNA-PK, and 8-hydroxy-2-methylquinazolin-4-one (NU1025), a PARP inhibitor] on cell survival and DNA double-strand break (DSB) and single-strand break (SSB) rejoining in Chinese hamster ovary-K1 cells following exposure to ionizing radiation (IR) or temozolomide. WM (20 microM) or NU1025 (300 microM) potentiated the cytotoxicity of IR with dose enhancement factors at 10% survival (DEF10) values of 4.5 +/- 0.6 and 1.7 +/- 0.2, respectively. When used in combination, a DEF10 of 7.8 +/- 1.5 was obtained. WM or NU1025 potentiated the cytotoxicity of temozolomide, and an additive effect on the DEF10 value was obtained with the combined inhibitors. Using the same inhibitor concentrations, their single and combined effects on DSB and SSB levels following IR were assessed by neutral and alkaline elution. Cells exposed to IR were post-incubated for 30 min to allow repair to occur. WM or NU1025 increased net DSB levels relative to IR alone (DSB levels of 1.29 +/- 0.04 and 1.20 +/- 0.05, respectively, compared with 1.01 +/- 0.03 for IR alone) and the combination had an additive effect. WM had no effect on SSB levels, either alone or in combination with NU1025. SSB levels were increased to 1.27 +/- 0.05 with NU1025 compared with IR alone, 1.02 +/- 0.04. The dose-dependent effects of the inhibitors on DSB levels showed that they were near maximal by 20 microM WM and 300 microM NU1025. DSB repair kinetics were studied. Both inhibitors increased net DSB levels over a 3 h time period; when they were combined, net DSB levels at 3 h were identical to DSB levels immediately post-IR. The combined use of DNA repair inhibitors may have therapeutic potential.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology*
  • Animals
  • Antineoplastic Agents / toxicity
  • CHO Cells / drug effects
  • Cell Survival / drug effects
  • Cricetinae
  • DNA / drug effects
  • DNA / radiation effects
  • DNA Damage
  • DNA Repair / drug effects*
  • DNA, Single-Stranded / drug effects
  • DNA, Single-Stranded / radiation effects
  • DNA-Activated Protein Kinase
  • DNA-Binding Proteins*
  • Dacarbazine / analogs & derivatives
  • Dacarbazine / toxicity
  • Drug Interactions
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology*
  • Poly(ADP-ribose) Polymerase Inhibitors*
  • Poly(ADP-ribose) Polymerases / metabolism
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*
  • Protein Serine-Threonine Kinases / metabolism
  • Quinazolines / pharmacology*
  • Temozolomide
  • Wortmannin


  • Androstadienes
  • Antineoplastic Agents
  • DNA, Single-Stranded
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • NU 1025
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Quinazolines
  • Dacarbazine
  • DNA
  • Poly(ADP-ribose) Polymerases
  • DNA-Activated Protein Kinase
  • Protein Serine-Threonine Kinases
  • Wortmannin
  • Temozolomide